美国食品和药物管理局(FDA)的一个咨询委员会,已谨慎地推荐应给一种新的抗莱姆病菌苗颁发许可证。在临床试验期间,发现使用3次该菌苗预防莱姆病十分有效。尽管该咨询委员会同意生产商 Smith Kline Beecham公司提交的资料显示该菌苗安全有效,符合获得许可证的要求,但也透露了一些保留意见。委员会成员之一科罗拉多大学传染病学教研室的 Theodore Eickhoff 博士说: An advisory committee of the US Food and Drug Administration (FDA) has carefully recommended that a new vaccine for Lyme disease vaccine should be issued. During the clinical trial, it was found that the use of the bacterin 3 times to prevent Lyme disease was very effective. Although the Advisory Committee agreed that the information submitted by the producer Smith Kline Beecham showed that the vaccine was safe and effective and met the requirements for obtaining a permit, it also disclosed some reservations. Dr. Theodore Eickhoff of the Department of Infectious Diseases at the University of Colorado, a member of the committee, said: